Account
Datsun to sell vehicles directly through Nissan Motor in India
MUMBAI: The launch of the Datsun GO is now just months away, and when the first model goes on sale in early 2014 the vehicles will be sold directly through Nissan Motor in India.
Datsun global head Vincent Cobee said in a release: “Selling the Datsun GO and future Datsun models through Nissan Motor represents a natural evolution of the company’s operations in India, which are well recognised in the market. We are excited about launching the iconic Datsun brand in India and look forward to bringing a growing range of bespoke, locally-produced products and high level services to our customers.”
 |
Cobee further added that an expanded model range will follow the introduction of the Datsun GO, a hatchback model that received positive reviews when it was revealed to the press and public earlier this year.
Datsun will work primarily with existing dealer investors who have already demonstrated high capabilities and commitment to the Nissan brand in recent years. This arrangement will in particular allow Datsun to rapidly establish a top quality, expansive retail network and open the brand to a large segment of the potential market straight from the initial launch.
Datsun is one of three brands within the Nissan Motor portfolio, joining Nissan and Infiniti. When president and CEO Carlos Ghosn announced that the venerable Datsun brand would reemerge after three decades, he said that the brand would serve optimistic up-and-coming customers in India.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
